Menopausal vasomotor symptoms (VMS)
- Menopausal hormone therapy is most effective
- Add progestogen if uterus is present with systemic estrogen
- Nonhormonal: SSRI/SNRI, gabapentin + others
- Neurokinin antagonists offer targeted nonhormonal therapy
- Choose by VTE/cancer/CV risk + symptom burden
- Reassess need/dose periodically
Use at a glance
- Menopausal hormone therapy is most effective
Treatment options
- Nonhormonal: SSRI/SNRI, gabapentin + others
- Neurokinin antagonists offer targeted nonhormonal therapy
Choosing treatment
- Add progestogen if uterus is present with systemic estrogen
Monitoring / follow-up
- Choose by VTE/cancer/CV risk + symptom burden
- Reassess need/dose periodically
Self-check
- What factors should guide treatment choice for Menopausal vasomotor symptoms (VMS)?
VTE/cancer/CV risk + symptom burden.
Drugs used for this (4)
All clinical uses · Open the interactive console ↗
